1. Home
  2. PCAP vs USBC Comparison

PCAP vs USBC Comparison

Compare PCAP & USBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCAP
  • USBC
  • Stock Information
  • Founded
  • PCAP 2025
  • USBC N/A
  • Country
  • PCAP United States
  • USBC
  • Employees
  • PCAP N/A
  • USBC 6
  • Industry
  • PCAP
  • USBC
  • Sector
  • PCAP
  • USBC
  • Exchange
  • PCAP Nasdaq
  • USBC Nasdaq
  • Market Cap
  • PCAP 324.1M
  • USBC 317.2M
  • IPO Year
  • PCAP 2025
  • USBC N/A
  • Fundamental
  • Price
  • PCAP $10.38
  • USBC $1.02
  • Analyst Decision
  • PCAP
  • USBC
  • Analyst Count
  • PCAP 0
  • USBC 0
  • Target Price
  • PCAP N/A
  • USBC N/A
  • AVG Volume (30 Days)
  • PCAP 78.8K
  • USBC N/A
  • Earning Date
  • PCAP 01-01-0001
  • USBC N/A
  • Dividend Yield
  • PCAP N/A
  • USBC N/A
  • EPS Growth
  • PCAP N/A
  • USBC N/A
  • EPS
  • PCAP N/A
  • USBC N/A
  • Revenue
  • PCAP N/A
  • USBC N/A
  • Revenue This Year
  • PCAP N/A
  • USBC N/A
  • Revenue Next Year
  • PCAP N/A
  • USBC N/A
  • P/E Ratio
  • PCAP N/A
  • USBC N/A
  • Revenue Growth
  • PCAP N/A
  • USBC N/A
  • 52 Week Low
  • PCAP $9.64
  • USBC N/A
  • 52 Week High
  • PCAP $11.42
  • USBC N/A
  • Technical
  • Relative Strength Index (RSI)
  • PCAP N/A
  • USBC 50.87
  • Support Level
  • PCAP N/A
  • USBC $0.78
  • Resistance Level
  • PCAP N/A
  • USBC $1.29
  • Average True Range (ATR)
  • PCAP 0.00
  • USBC 0.13
  • MACD
  • PCAP 0.00
  • USBC 0.02
  • Stochastic Oscillator
  • PCAP 0.00
  • USBC 48.09

About PCAP ProCap Acquisition Corp Class A Ordinary Shares

ProCap Acquisition Corp is a blank check company.

About USBC USBC Inc. Common Stock

USBC Inc is a non-invasive medical diagnostics. The group is focused on the development and commercialization of proprietary sensor technology utilizing radio and microwave dielectric spectroscopy. Its Sensor technology elicits a dielectric response that is different for every molecule. The group considers the business to currently have one operating segment: the development of its radio frequency spectroscopy technology, with a first focus on non-invasively ascertaining blood glucose levels.

Share on Social Networks: